ICH S6 (R1) Preclinical safety evaluation of biotechnology-derived pharmaceuticals - Scientific guideline

HumanScientific guidelines

Hungarian is available via eTranslation, the European Commission's machine translation service.

Translate to Hungarian | Important information about machine translation

This document aims to recommend a basic framework for the preclinical safety evaluation of biotechnology-derived pharmaceuticals. It applies to products derived from characterised cells through the use of a variety of expression systems including bacteria, yeast, insect, plant, and mammalian cells.

Keywords: Non-clinical safety, biotechnology-derived pharmaceuticals, species selection, pharmacokinetics, toxicology

Current effective version - Revision 1

Share this page